Faron Pharmaceuticals

View the org chart displaying its 13 main executives

Most searched biographies at Faron Pharmaceuticals

• Juho Jalkanen, Director and Chief Executive Officer
• Erik Ostrowski, Non-Executive Director
• Markku Jalkanen, Director

Popular executive movements at Faron Pharmaceuticals

• Juho Jalkanen, who was Chief Operating Officer, is promoted to Director and Chief Executive Officer  (posted on May 6 2024).
• Yrjoe Wichmann, who was Senior Vice President, Funding and Ir, is promoted to Interim Chief Financial Officer  (posted on April 16 2024).
• James O'Brien, Chief Financial Officer, has left the company  (posted on April 16 2024).

Click here to view some more movements at Faron Pharmaceuticals

Create your alert
to follow the executive moves at Faron Pharmaceuticals.

Faron Pharmaceuticals has 1,853 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• LakeShore Biopharma will change its company name to LakeShore Biopharma on May 24, 2024. (posted on May 25 2024).
• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Anat Ashkenazi - Senior Vice President and Chief Financial Officer (until Jul 31 2024) at Eli Lilly
• Robert Langer - Board Member at Moderna

Learn more about the Pharmaceuticals industry >

Press releases by Faron Pharmaceuticals

• Other Releases | Faron

Social media about Faron Pharmaceuticals

• Faron Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Faron Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Juho Jalkanen

Call Faron Pharmaceuticals at +358 ...

View the org chart

Register to receive your alert

Report an error